Contact UsInvestorsCareersScienceContact Us
Investor Relations

STATUTORY COMMUNICATIONS 2024 - 2025

Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation regarding change in Senior Management Personnel of the Company

Pfizer Limited – Notice of closure for Trading Window – June 30, 2024

Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Contact details of the authorized Key Managerial Personnel for determining materiality of an event or information

Disclosure on Related Party Transactions as on March 31, 2024

Pfizer Limited – Notice for the Board Meeting – May 17, 2024

Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation regarding appointment of Cost Auditors

Pfizer Limited – Results of the Postal Ballot E-voting – April 2, 2024

About UsOur PeopleOur Community EffortsOur ProductsInvestorsCareerMediaAdverse Event ReportingHealth Care ProfessionalsTerms of UsePrivacy PolicyContact UsCopyright © 2002- 2021 Pfizer Inc. All rights reserved.